Health TrialsbyHealthPanel

Risk Factors of Venous Thrombotic Event in Interstitial Lung Disease

ConditionsInterstitial Lung DiseaseVenous ThromboembolismPulmonary EmbolismDeep Venous Thrombosis
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorSohag University

About this trial

This study aims to determine the incidence of venous thromboembolic events (VTE), including deep vein thrombosis (DVT) and pulmonary embolism (PE), among hospitalized patients with interstitial lung disease (ILD). It will also identify potential risk factors associated with VTE and evaluate its impact on clinical outcomes. Patients with ILD admitted to the hospital will be assessed for clinical characteristics, disease severity, risk factors for thrombosis, and the occurrence of DVT or PE during hospitalization. The study findings may help improve early recognition of VTE and guide appropriate preventive and diagnostic strategies in hospitalized patients with ILD.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Age ≥ 18 years. Patients admitted to the respiratory ICU, Chest Department

Disqualifiers

Age < 18 years. Patients already receiving therapeutic anticoagulation before admission. Known inherited thrombophilia. Active malignancy. Pregnancy. Patients refusing participation. Recent major surgery or trauma within previous 4 weeks.

Trial population

"The study will include adult patients aged 18 years or older who are admitted to the Department of Chest Diseases, Sohag University Hospital, with a confirmed diagnosis of interstitial lung disease (ILD). Eligible patients will be assessed for risk factors, clinical characteristics, and occurrence of venous thrombotic events during hospitalization.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

Not listed

Trial groups

100 Participants
are grouped into 1 trial group
Group A: One group

Trial outcomes

Primary outcomes

1

Primary outcome: Incidence of venous thromboembolic events (VTE)

Number and proportion of adult patients with ILD who develop objectively confirmed venous thromboembolic events, defined as DVT and/or pulmonary embolism, during hospitalization.

Time frame
One Year

Secondary outcomes

1

Length of hospital stay

Time frame
One year
2

Requirement and level of respiratory support

Time frame
One Year
3

ICU admission and length of ICU stay

Time frame
One Year
4

In-hospital mortality

Time frame
One Year

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

Sohag University

Lead sponsor

Source ClinicalTrials.gov

This trial is not recruiting at the moment. You can still explore other options: